Drug Target Review2024-01-30T16:00:07
A new project plans to elucidate the relationship between the glucosylceramidase beta gene and Parkinson’s disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-11-10T13:56:00Z
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2023-10-06T10:52:00
Contributor Dr David Lonard
2024-02-06T08:57:06
Sponsored by bit.bio
2026-07-31T06:00:00
Contributor Dr Davinder Ramsingh, Drug Target Review
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2026-09-23T15:00:00
Sponsored by BioIVT
Site powered by Webvision Cloud